Condition

Metastatic HER2 Negative Breast Carcinoma (2)

Anatomic Stage IV Breast Cancer AJCC v8 (1)

Brain Metastases (1)

Capecitabine (1)

Invasive Breast Carcinoma (1)

Metastatic Malignant Neoplasm in the Brain (1)

Prognostic Stage IV Breast Cancer AJCC v8 (1)

UDT1 (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Hunan Cancer Hospital (1)

Southwest Oncology Group (1)

Collaborator

Gilead Sciences (1)

National Cancer Institute (NCI) (1)

Intervention

sacituzumab govitecan (1)

utd1 combined with capecitabine (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

Other (2)

Study Type

Interventional (2)

metastatic her2 negative breast carcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Metastatic HER2 Negative Breast Carcinoma, Brain Metastases, Capecitabine Trial in Changsha (UTD1 combined with capecitabine)

Recruiting

Metastatic HER2 Negative Breast Carcinoma
+3 more

UTD1 combined with capecitabine

Changsha, China

Quchang Ouyang

Sep 9, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Metastatic HER2 Negative Breast Carcinoma Trial in United

Recruiting

Anatomic Stage IV Breast Cancer AJCC v8
+4 more

Sacituzumab Govitecan

Anchorage, Alaska
+295 more

Jul 20, 2022